Tenet Healthcare (THC) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket
 


Tenet Healthcare Corp  (NYSE: THC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Tenet Healthcare's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Tenet Healthcare in the third quarter 2026?
Tenet Healthcare Corp achieved a return on average equity (ROE) of 57.13 % in its third quarter 2026, this is above THC's average return on equity of 15.51%.
Tenet Healthcare Corps equity during the 12 months ending in the third quarter 2026 are valued at $6 billion

ROE has advanced compared to 50.64% in the second quarter 2026, due to net income growth.

Within the Healthcare Facilities industry only one company had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 219, from total ROE ranking in the second quarter 2026 at 263.

What is ROE?




Return On Equity (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Equity Change 28.22 % 19.74 % 14.22 % 3.38 % -
Y / Y Net Income Change 110.54 % 100.19 % 45.66 % 12.59 % -14.98 %
Net Income (TTM) in Millions 3,814 3,174 2,651 2,367 2,295
Return On Equity (TTM) 57.13 % 50.64 % 44.2 % 40.89 % 39.99 %
THC's Total Ranking # 219 # 263 # 236 # 208 # 214
Equity (TTM) in Millions 7,415 6,557 6,713 6,017 5,783
Seq. Equity Change 13.09 % -2.32 % 11.57 % 4.05 % 5.61 %
Seq. Net Income Change 16.65 % 15.34 % 40.68 % 11.23 % 10.92 %

Return On Equity Company Ranking
Within: No.
Industry # 2
Sector # 36
Overall # 219

Return On Equity Statistics
High Average Low
171.02 %
15.51 %
-333.33 %
(March 30, 2009)   (June 30, 2008)



  News about Tenet Healthcare Corp Return on Equity ROE

Tenet Healthcares Strategic Move A Bold Step in Optimising Healthcare Operations

In a significant shift for Tenet Healthcare Corporation, the company has recently completed the sale of its 70% majority ownership interest in Brookwood Baptist Health in Birmingham to Orlando Health. This monumental transaction, concluded on the back of previously disclosed terms, encompasses a network of five hospitals: Brookwood Baptist Medical Center, Citizens Baptist Medical Center, Princeton Baptist Medical Center, Shelby Baptist Medical Center, and Walker Baptist Medical Center, alongside other related operations. This strategic divestiture is more than just a financial maneuver; it represents Tenet s commitment to refining its operational focus and enhancing shareholder value in an increasingly competitive healthcare landscape. By offloading these facilities, Tenet is poised to redirect its resources and strategic attention toward areas of stronger growth and profitability.In its second quarter of 2024, Tenet Healthcare showcased remarkable financial agility, marking a staggering return on equity (ROE) of 88.36%. This figure significantly eclipses the company’s average ROE of 10.66% and underscores Tenet s exceptional performance within the healthcare facilities sector, where it secured the highest ROE among its competitors. However, it’s worth noting that this ROE marks a decline relative to previous periods, influenced by a dip in net income. Nonetheless, Tenet has managed to improve its overall ranking from 60 to 57 in terms of ROE within the financial landscape, further highlighting its robust operational capabilities.




THC Annual Return On Equity (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Equity in Millions 6,017 5,820 3,117 2,459 2,054
Y / Y Equity Change 3.38 % 86.72 % 26.76 % 19.72 % 119.21 %
Net Income in Millions 2,367 4,064 1,311 1,001 1,476
Y / Y Net Income Change -41.76 % 209.99 % 30.97 % -32.18 % 92.19 %
Return On Equity 39.34 % 69.83 % 42.06 % 40.71 % 71.86 %





Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 39.34 %, due to deterioration of net income.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
THC's' Return on Equity at Yahoo Finance
THC's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for THC's Competitors
Subscribers only: Roe for Tenet Healthcare's Suppliers
Subscribers only: Return On Equity for THC's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Amneal Pharmaceuticals Inc   157.05 %
Alector Inc   112.21 %
Medpace Holdings Inc   99.76 %
3m Company  93.07 %
Exelixis Inc   85.83 %
Amgen Inc   85.59 %
Eli Lilly And Company  83.65 %
Rigel Pharmaceuticals Inc  73.94 %
Idexx Laboratories Inc  71.18 %
Tenet Healthcare Corp  57.13 %
Aurinia Pharmaceuticals Inc   51.92 %
Nurix Therapeutics Inc   49.34 %
Carlisle Companies Incorporated  44.18 %
Bristol myers Squibb Company  43.83 %
Zevra Therapeutics Inc   38.02 %
Dexcom Inc   36.56 %
Rallybio Corporation  36.35 %
Caredx Inc   34.08 %
Chemed Corporation  32.10 %
Illumina Inc   31.45 %
Transmedics Group Inc   28.74 %
Acadia Pharmaceuticals Inc   28.03 %
Pro dex Inc   26.91 %
Sotera Health Company  26.41 %
Pacs Group Inc   25.65 %
Standard Biotools Inc   25.58 %
Resmed Inc   25.50 %
Bioventus Inc   24.60 %
Encompass Health Corporation  24.08 %
Iradimed Corporation  23.90 %


Date modified: 2026-10-30T13:25:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.